Literature DB >> 35911662

The Coronary Angiography-Derived Index of Microcirculatory Resistance Predicts Left Ventricular Performance Recovery in Patients with ST-Segment Elevation Myocardial Infarction.

Chang Hou1,2, Meng Guo1,2, Yuliang Ma1,2, Qi Li1,2, Chuanfen Liu1,2, Mingyu Lu1,2, Hong Zhao1,2, Jian Liu1,2.   

Abstract

Objectives: The present study is designed to investigate the impact of coronary angiography-derived index of microcirculatory resistance (caIMR) on left ventricular performance recovery. Background: IMR has been established as a gold standard for coronary microvascular assessment and a predictor of left ventricular recovery after ST-segment elevation myocardial infarction (STEMI). CaIMR is a novel and accurate alternative of IMR.
Methods: The present study retrospectively included 80 patients with STEMI who underwent primary percutaneous coronary intervention (PCI). We offline performed the post-PCI caIMR analysis of the culprit vessel. Echocardiography was performed within the first 24 hours and at 3 months after the index procedure. Left ventricular recovery was defined as the change in left ventricular ejection fraction (LVEF) more than zero.
Results: The mean age of the patients was 58.0 years with 80.0% male. The average post-PCI caIMR was 43.2. Overall left ventricular recovery was seen in 41 patients. Post-PCI caIMR (OR: 0.948, 95% CI: 0.916-0.981, p = 0.002), left anterior descending as the culprit vessel (OR: 3.605, 95% CI: 1.23-10.567, p = 0.019), and male (OR: 0.254, 95% CI: 0.066-0.979, p = 0.047) were independent predictors of left ventricular recovery at 3 months follow-up. A predictive model was established with the best cutoff value for the prediction of left ventricular recovery 2.33 (sensitivity 0.610, specificity 0.897, and area under the curve 0.765). In patients with a predictive model score less than 2.33, the LVEF increased significantly at 3 months. Conclusions: The post-PCI caIMR can accurately predict left ventricular functional recovery at 3 months follow-up in patients with STEMI treated by primary PCI, supporting its use in clinical practice.
Copyright © 2022 Chang Hou et al.

Entities:  

Mesh:

Year:  2022        PMID: 35911662      PMCID: PMC9303485          DOI: 10.1155/2022/9794919

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   1.776


1. Introduction

Although primary percutaneous coronary intervention (PCI) can restore the blood flow of the epicardial coronary artery, coronary microvascular dysfunction (CMD) still exists in patients with ST-segment elevation myocardial infarction (STEMI) [1]. The post-PCI hyperemic index of microcirculatory resistance (IMR) obtained by pressure wire is a useful tool for the assessment of CMD and can effectively predict left ventricular recovery at 3 months post-STEMI [2-4]. However, the clinical adoption of IMR remains limited mainly due to additional cost and procedural complexity. Coronary angiography-derived IMR (caIMR) is an emerging computed index to evaluate coronary microcirculation without physiology wire and adenosine [5], which shows accurate diagnostic performance for CMD and great long-term prognostic value in previous studies [6-15]. However, the impact of post-PCI caIMR on left ventricular performance recovery at 3 months in patients with STEMI remains unknown. The aim of the present study is to examine whether caIMR can predict left ventricular recovery at 3 months after the index procedure.

2. Materials and Methods

2.1. Study Population

The present study consecutively enrolled 134 patients with STEMI who underwent primary PCI at Peking University People's Hospital (Beijing, China) between July 2016 and December 2021. STEMI was defined using the fourth universal definition of myocardial infarction [16]. The exclusion criteria were as follows: merely coronary angiography without stent implantation, coronary artery bypass graft rather than PCI, lack of echocardiography within the first 24 hours and after 3 months, and poor angiographic image quality precluding the contour detection and caIMR calculation.

2.2. Study Design

This was a retrospective study to evaluate the predictive ability of post-PCI caIMR on left ventricular performance recovery at 3 months in patients with STEMI. We searched and reviewed medical records, coronary angiography, and echocardiography images of the eligible patients. The patient's demographic information, cardiovascular risk factors, hemodynamic parameters, laboratory examinations, discharge medications, lesion, and procedural characteristics were recorded.

2.2.1. PCI Procedure and Coronary Microcirculation Assessment

Coronary angiography and stent implantation were performed according to the standard protocol. An image acquisition speed of 30 frames per second was used. The thrombolysis in myocardial infarction (TIMI) flow grade was assessed in all patients. Corrected TIMI frame count (cTFC) was calculated as previously described [17]. The caIMR analysis of infarction related artery (IRA) after PCI was achieved offline by using commercialized software (FlashAngio, Rainmed Ltd., Suzhou, China) as described in literature [8]. In brief, a three-dimensional reconstruction was first conducted for the interrogated vessel; then coronary angiography-derived fractional flow reserve (caFFR) was estimated by computational pressure-flow dynamics with a validated method; and the hyperemic Pa (Pahyp) was assumed by mean arterial pressure during the index procedure. Thus, caIMR was calculated as follows:where L represents the length from the inlet to the distal position; Pdhyp is the mean pressure at the distal position at the maximal hyperemia, which is computed by the software as the product of Pahyp and caFFR; Vdiastole is the mean flow velocity at the distal position at diastole, which is derived using the cTFC method, and selection of the diastolic period is based on the movement of the tip of the guiding catheter; [12] and K is a constant (K = 2.1). Two independently trained cardiologists who were blinded to clinical data and echocardiography results performed the analysis. Any contradictions were resolved by consensus.

2.3. Echocardiography Measurement and Analysis

Echocardiography was performed within the first 24 hours and at 3 months after PCI by two experienced cardiologists who were blinded to the clinical and coronary physiological information using an available ultrasound system (Vivid 7, GE Medical Systems, NY, USA). Left ventricular ejection fraction (LVEF) was measured from the four and two-chamber areas using the modified Simpson's rule. Wall motion score index (WMSI) was calculated according to the European society of echocardiography recommendations, using the 17-segment model on a 1–5 scale ((1) normal, (2) hypokinesia, (3) akinesia, (4) dyskinesia, and (5) aneurysmal) [18]. Global longitudinal strain (GLS) was assessed using speckle-tracking analysis and obtained from two-dimensional gray scale images of three standard apical views with optimal frame rate. Peak longitudinal strain was defined as the percent change in length of the myocardium from end-diastole to end-systole. The mean of the peak systolic longitudinal strain values from the 17 segments was calculated to determine GLS [19]. The change in LVEF, WMSI, and GLS was calculated by subtracting the baseline results from the follow-up ones. The definition of left ventricular recovery was an improvement in LVEF (i.e., the change in LVEF is more than zero) at 3 months.

2.4. Statistical Analysis

Statistical analysis was performed using the SPSS software (version 24.0, IBM Corp., NY, USA). Categorical variables were presented as frequency (%) and compared using the χ2 or Fisher's exact test, as appropriate. Continuous variables with normal distribution were presented as mean ± standard deviation, otherwise presented as median and interquartile range, which were compared using Student's t-test or Mann–Whitney U test, as appropriate. Bivariate correlation analysis was performed to assess the relationships between variables. The univariate logistic regression model was built and variables with p < 0.10 entered in the multivariate analysis. The factors that were deemed to be clinically relevant (age, sex, current smoking, and diabetes) were also incorporated. Then, we investigated the independent determinants of left ventricular recovery with a stepwise algorithm in the multivariate logistic regression analysis, and significant variables were included in the final predictive model. Similar to the method of risk score establishment proposed in Framingham' study [20], a model was developed by assigning weighted points for each variable, and a total score was calculated for each patient. Receiver operating characteristic (ROC) curve analysis was used to determine the best cutoff value and area under the curve (AUC) for the predictive model. The interobserver agreements for caIMR analysis were evaluated by calculating the intraclass correlation coefficients (ICC). A two-sided p value < 0.05 was considered to indicate a statistically significant difference.

3. Results

A total of 134 patients with STEMI who underwent primary PCI were screened for the present study. Of the 54 patients excluded, 2 required surgical revascularization, 4 received only coronary angiography, 47 lacked echocardiography within the first 24 hours or after 3 months, and in 1 patient, the angiographic image was unable to analyze due to poor quality. Thus, 80 patients were finally included (Figure 1).
Figure 1

Study flowchart.

The mean age of the patients was 58.0 ± 12.7 years. More than half of the patients had the coexisting risk factors of hypertension and smoking. The IRA was left anterior descending (LAD) in 51 patients, left circumflex in 8 patients, and right coronary in 21 patients. The time from symptom onset-to-balloon dilation was 7 (3.5–21.875) hours. Procedural success with TIMI flow grade 3 was achieved in 74 patients. Mean post-PCI caFFR and caIMR were 0.93 and 43.2, respectively. At discharge, all patients without contraindication were on therapy with aspirin, P2Y12 inhibitors, and statins, and most of the patients used β-blockers, angiotensin converting enzyme inhibitors, or angiotensin receptor blockers (Table 1).
Table 1

Clinical, angiographic, and procedural characteristics.

VariableTotal (n = 80)
Demographics
 Age (y)58.0 ± 12.7
 Male64 (80.0%)
 Body mass index (kg/m2)24.7 ± 3.3
Cardiovascular risk factors
 Hypertension50 (62.5%)
 Diabetes26 (32.5%)
 Hyperlipidemia39 (48.8%)
 Chronic kidney disease4 (5.0%)
 Current smoking47 (58.8%)
Previous PCI7 (8.8%)
Previous CABG1 (1.3%)
Hemodynamic parameters
 Systolic blood pressure (mmHg)125.5 ± 19.4
 Diastolic blood pressure (mmHg)72.7 ± 10.4
Cardiac function (Killip class)
 I65 (81.3%)
 II8 (10.0%)
 III1 (1.3%)
 IV6 (7.5%)
Culprit vessel
 Left anterior descending51 (63.7%)
 Left circumflex8 (10.0%)
 Right coronary artery21 (26.3%)
Multivessel disease61 (76.3%)
Symptom onset-to-balloon time (h)7 (3.5–21.875)
Thrombus aspiration7 (8.8%)
Glycoprotein IIb/IIIa inhibitor use8 (10.0%)
Adjunctive balloon dilatation5 (6.3%)
Total number of stents1 (1-2)
Mean stent diameter (mm)3.0 (2.75–3.5)
Total length of stents (mm)32 (24–46)
Post-PCI TIMI flow grade
 26 (7.5%)
 374 (92.5%)
Coronary physiological measurements
 cTFC22.98 ± 13.00
 caFFR0.93 (0.89–0.94)
 caIMR43.2 ± 16.1
Laboratory profiles
 Peak troponin I (ng/ml)19742.35 (81.00–74380.48)
 Peak CK-MB (ng/ml)180.79 (56.02–238.48)
 C-reactive protein (mg/L)8.8 (1.0–30.3)
 Low-density lipoprotein cholesterol (mmol/L)2.88 ± 0.87
 Estimated glomerular filtration rate (ml/min1.73 m2)87.4 ± 20.6
Discharge medication
 Aspirin80 (100%)
 P2Y12 inhibitor80 (100%)
 Statins80 (100%)
 Beta-blocker66 (82.5%)
 ACEI/ARB60 (75.0%)

PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; TIMI, thrombolysis in myocardial infarction; cTFC, corrected thrombolysis in myocardial infarction frame count; caFFR, coronary angiography-derived fractional flow reserve; caIMR, coronary angiography-derived index of microcirculatory resistance; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker.

The LVEF increased numerically at 3 months after the index procedure without significant difference compared to baseline. However, both WMSI (1.50 (1.24–1.88) vs 1.31 (1.08–1.63), p < 0.001) and GLS (−12.2 ± 4.0 vs −14.1 ± 4.0, p = 0.001) improved significantly at 3 months follow-up (Table 2). 41 of all patients showed left ventricular recovery. The mean post-PCI caIMR and cTFC were significantly lower in the patients with left ventricular recovery at 3 months (38.3 ± 15.5 vs. 48.4 ± 15.2, p = 0.004 and 20.2 ± 11.7 vs. 26.0 ± 13.7, p = 0.045, respectively). There was no significant difference in other physiological indices between the recovery and no recovery groups (Table 3).
Table 2

Baseline and 3 months echocardiographic parameters.

ParameterBaseline3 months P value
LVEF56.3 ± 11.256.7 ± 10.00.661
WMSI1.50 (1.24–1.88)1.31 (1.08–1.63)<0.001
GLS−12.2 ± 4.0−14.1 ± 4.00.001

LVEF, left ventricular ejection fraction; WMSI, wall motion score index; GLS, global longitudinal strain.

Table 3

Measures of microvascular function in patients with and without left ventricular recovery at 3 months.

VariableRecovery (n = 41)No recovery (n = 39) P value
TIMI flow grade 339 (95.1%)35 (89.7%)0.625
cTFC20.2 ± 11.726.0 ± 13.70.045
caFFR0.92 (0.90–0.945)0.93 (0.88–0.93)0.227
caIMR38.3 ± 15.548.4 ± 15.20.004

TIMI, thrombolysis in myocardial infarction; cTFC, corrected thrombolysis in myocardial infarction frame count; caFFR, coronary angiography-derived fractional flow reserve; caIMR, coronary angiography-derived index of microcirculatory resistance.

The post-PCI caIMR did not correlate with baseline and 3-month LVEF (r = 0.074, p = 0.512 and r = −0.169, p = 0.135, respectively). However, there was a significant inverse correlation between post-PCI caIMR and the change in LVEF (r = −0.330, p = 0.003, Figure 2). The change in LVEF, WMSI, and GLS all did not correlate with other measures of microvascular function.
Figure 2

A significant inverse correlation found between coronary angiography-derived index of microcirculatory resistance after primary percutaneous coronary intervention and the change in left ventricular ejection fraction (r = −0.330, p = 0.003).

In the univariate analysis, the peak CK-MB, post-PCI cTFC, and caIMR were significant predictors of left ventricular recovery at 3 months. The variables of age, sex, current smoking, hypertension, diabetes, hyperlipidemia, peak CK-MB, LAD as the culprit vessel, post-PCI cTFC, and caIMR were included for multivariate analysis. Then, the post-PCI caIMR (OR: 0.948, 95% CI: 0.916–0.981, p = 0.002), LAD as the culprit vessel (OR: 3.605, 95% CI: 1.23–10.567, p = 0.019), and male (OR: 0.254, 95% CI: 0.066–0.979, p = 0.047) were found to be independent predictors of left ventricular recovery in the multivariate logistic regression model (Table 4). The points were assigned based on regression coefficients, and we established a final predictive model as 0.054 × caIMR − 1.282 × LAD as the culprit vessel + 1.372 × male.
Table 4

Logistic regression analysis for the left ventricular recovery at 3 months.

UnivariableOdds ratio95% CI P value
Age1.0180.983–1.0550.316
Male0.4010.125–1.2870.124
Hypertension0.4550.180–1.1520.097
Diabetes0.9290.364–2.3670.877
Hyperlipidemia0.4450.182–1.0890.076
Current smoking0.5250.212–1.2970.163
Cardiac function (Killip class)0.9750.578–1.6450.926
Peak CK-MB0.9950.990–1.0000.047
Multivessel disease0.7040.249–1.9910.508
LAD as the culprit vessel2.3380.918–5.9530.075
Post-PCI TIMI flow grade2.2290.384–12.9230.372
cTFC0.9640.930–1.0000.050
caFFR0.0160–16.6690.243
caIMR0.9570.927–0.9880.007
MultivariableOdds ratio95% CI P value
Male0.2540.066–0.9790.047
LAD as the culprit vessel3.6051.230–10.5670.019
caIMR0.9480.916–0.9810.002

LAD, left anterior descending; TIMI, thrombolysis in myocardial infarction; cTFC, corrected thrombolysis in myocardial infarction frame count; caFFR, coronary angiography-derived fractional flow reserve; caIMR, coronary angiography-derived index of microcirculatory resistance.

We then identified the optimal threshold for the prediction of left ventricular recovery by ROC curve analysis. The best cutoff value of the predictive model was 2.33 (sensitivity 0.610, specificity 0.897, AUC 0.765, 95% CI: 0.660–0.871, and p < 0.001) (Figure 3). The best cutoff value of the post-PCI caIMR alone was 40.9 with an AUC of 0.705.
Figure 3

Receiver operating characteristic curves of the novel proposed predictive model. The optimal threshold of the model for predicting left ventricular recovery at 3-month follow-up was 2.33 with sensitivity 0.610, specificity 0.897, and area under the curve 0.765 (p < 0.001).

Using 2.33 as the optimal cutoff value, 29 patients had a predictive model score less than 2.33. In patients with a predictive model score less than 2.33, the peak CK-MB, post-PCI cTFC, and caFFR were significantly lower. The proportion of multivessel disease was also significantly lower in these patients. There was no significant difference in the mean age, cardiovascular risk factors, blood pressure level, discharge medications, and ischemia time between the two groups (Table 5).
Table 5

Clinical variables and echocardiographic parameters of patients according to the optimal cutoff value for the predictive model.

VariableThe score < 2.33 (n = 29)The score ≥ 2.33 (n = 51) P value
Age (y)60.3 ± 15.656.7 ± 10.70.274
Body mass index (kg/m2)24.4 ± 3.924.9 ± 2.90.453
Hypertension15 (51.7%)35 (68.6%)0.133
Diabetes7 (24.1%)19 (37.3%)0.229
Hyperlipidemia12 (41.4%)27 (52.9%)0.320
Current smoking16 (55.2%)31 (60.8%)0.624
Systolic blood pressure (mmHg)125.1 ± 19.6125.8 ± 19.50.888
Diastolic blood pressure (mmHg)69.8 ± 11.074.4 ± 9.80.058
Multivessel disease18 (62.1%)43 (84.3%)0.025
Symptom onset-to-balloon time (h)8.0 (4.5–24.5)6.0 (3.5–16.2)0.312
Thrombus aspiration0 (0.0%)7 (13.7%)0.094
Glycoprotein IIb/IIIa inhibitor use2 (6.9%)6 (11.8%)0.756
Post-PCI TIMI flow grade 327 (93.1%)47 (92.2%)0.877
cTFC17.6 ± 9.026.0 ± 14.00.002
caFFR0.905 (0.83–0.925)0.93 (0.91–0.945)0.001
Peak troponin I (ng/ml)9313.0 (40.9–54053.55)25682.9 (82.0–91652.2)0.091
Peak CK-MB (ng/ml)80.9 (31.36–226.65)194.0 (104.3–243.4)0.039
Beta-blocker23 (79.3%)43 (84.3%)0.571
ACEI/ARB23 (79.3%)37 (72.5%)0.502
Change in LVEF5.5 ± 6.6−2.5 ± 6.6<0.001
Change in WMSI−0.05 (−0.25–0)−0.16 (−0.47–−0.03)0.165
Change in GLS−2.4 ± 3.4−1.8 ± 3.80.610

TIMI, thrombolysis in myocardial infarction; cTFC, corrected thrombolysis in myocardial infarction frame count; caFFR, coronary angiography-derived fractional flow reserve; caIMR, coronary angiography-derived index of microcirculatory resistance; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; LVEF, left ventricular ejection fraction; WMSI, wall motion score index; GLS, global longitudinal strain.

The LVEF increased significantly in patients with a predictive model score less than 2.33 (58.4 ± 11.3 vs 53.0 ± 12.8, p < 0.001), whereas it decreased significantly in the other group (55.7 ± 9.1 vs. 58.2 ± 9.8, p = 0.009). The WMSI was significantly lower at 3-month follow-up compared to baseline only in patients with a score more than or equal to 2.33 (1.31 (1.06–1.60) vs. 1.47 (1.21–1.94), p < 0.001). The GLS improved significantly in both the groups (−13.5 ± 4.3 vs. −11.5 ± 3.3, p = 0.015 and −14.4 ± 3.9 vs. −12.6 ± 4.3, p = 0.026, respectively) (Table 6). A significant difference was observed for the change in LVEF between the two groups (5.5 ± 6.6 vs. −2.5 ± 6.6, p < 0.001), while there was no difference for the change in WMSI and GLS (Table 5).
Table 6

Baseline and 3-month echocardiographic parameters according to the optimal cutoff value for the predictive model.

ParameterThe score < 2.33The score ≥ 2.33
Baseline3 months P valueBaseline3 months P value
LVEF53.0 ± 12.858.4 ± 11.3<0.00158.2 ± 9.855.7 ± 9.10.009
WMSI1.50 (1.31–1.78)1.38 (1.13–1.63)0.0771.47 (1.21–1.94)1.31 (1.06–1.60)<0.001
GLS−11.5 ± 3.3−13.5 ± 4.30.015−12.6 ± 4.3−14.4 ± 3.90.026

LVEF, left ventricular ejection fraction; WMSI, wall motion score index; GLS, global longitudinal strain.

There was a good concordance between two cardiologists for the measurement of post-PCI caIMR of the culprit vessels (ICC = 0.889, p < 0.001).

4. Discussion

The present study examines the predictive value of postprocedural caIMR for left ventricular functional recovery in patients with STEMI who undergo primary PCI. The key findings of the present study are as follows: (i) the post-PCI caIMR of the IRA is an independent predictor of left ventricular functional recovery at 3 months after the index procedure and (ii) the female patients with lower post-PCI caIMR, in whom the culprit vessel is LAD, show a more significant improvement in left ventricular functional indices including LVEF and GLS. Despite the success of primary PCI in IRA recanalization, approximately half of patients with STEMI show failure of myocardial reperfusion and CMD in the culprit vessel territory, which is a key determinant of adverse ventricular remodeling and clinical outcome [1]. Although many noninvasive imaging modalities are optimal for CMD assessment, they are not available at the cardiac catheterization laboratory during PCI [21]. The pressure wire-derived IMR measured immediately after PCI is a quantitative, reproducible index not affected by epicardial coronary artery stenosis under various hemodynamic perturbations and has been considered as a “gold standard” for CMD [2]. Overwhelming evidences suggest that IMR can accurately predict the size of myocardial infarction and remodeling of the left ventricle and microvascular obstruction in patients with STEMI treated by PCI [22-27]. Furthermore, IMR following PCI has the potential to predict left ventricular recovery at 3 months post-STEMI in patients managed with primary angioplasty and pharmacoinvasive strategies [3, 4]. It has also been found that the patients with a post-PCI mean IMR greater than 40 U have a higher rate of death or rehospitalization due to heart failure at 1 year in a multicenter study assessing 253 patients with STEMI [28]. However, due to the additional cost, extra procedural time, and risk associated with the manipulation of a pressure wire, patient discomfort caused by adenosine infusion, IMR has inevitable practical restrictions. Recently, some attempts have been made to calculate IMR based on coronary angiography without the need of a pressure wire and adenosine [5]. Tebaldi et al. proposed for the first time the formula of the angiography-based IMR, which shows a modest diagnostic performance for the prediction of IMR ≥ 25 [6]. Mejia–Renteria et al. developed a method applicable to functional angiography and demonstrated that estimation of IMR without physiological wires and adenosine is feasible [7]. Ai et al. confirmed the high diagnostic accuracy of caIMR using IMR as the reference standard in patients with ischemia and no obstructive coronary arteries [8]. Similarly, De Maria et al. validated that angiography-derived IMR is a promising alternative of invasive IMR to detect CMD in patients with STEMI and stable coronary artery disease [9, 10]. As a novel tool for the assessment of CMD, the pooled sensitivity and specificity of angiography-based IMR are 0.81 and 0.80, respectively, regardless of patients' presentation in a meta-analysis [11]. Consistent with previous studies, the post-PCI caIMR shows a great capability for the prediction of left ventricular functional recovery at 3 months in the present study, and the best cutoff value for caIMR is close to the well-established threshold of IMR to define CMD in STEMI [28]. In addition, the angiography-derived IMR after PCI has been confirmed as an independent predictor of long-term clinical outcome including cardiac death or readmission for heart failure in patients with STEMI and stable coronary artery disease [12-15]. The culprit vessel is LAD has been another independent predictor of left ventricular performance recovery in the present study, suggesting that the successful recanalization of LAD in STEMI treated with PCI is extremely important for the cardiac function. The present study has several limitations. First, the study is retrospective with a relatively small sample size. Thus, the established predictive model is not a real prospective prediction rather than only an internal validation. Second, our included patients fail to receive IMR measurements as a reference. Third, CMD in the IRA territory can be a dynamic phenomenon; therefore, a single caIMR value immediately after PCI might not fully explain patient prognosis. Next, there is a lack of evaluation of the underlying CMD in the nonculprit vessel territory. Finally, the clinical prognostic implication of caIMR has not been assessed.

5. Conclusions

The novel calculated caIMR after primary PCI shows a great value for the prediction of left ventricular functional recovery reflected by LVEF improvement at 3 months after the index procedure in patients with STEMI.
  28 in total

1.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Roberto M Lang; Luigi P Badano; Victor Mor-Avi; Jonathan Afilalo; Anderson Armstrong; Laura Ernande; Frank A Flachskampf; Elyse Foster; Steven A Goldstein; Tatiana Kuznetsova; Patrizio Lancellotti; Denisa Muraru; Michael H Picard; Ernst R Rietzschel; Lawrence Rudski; Kirk T Spencer; Wendy Tsang; Jens-Uwe Voigt
Journal:  J Am Soc Echocardiogr       Date:  2015-01       Impact factor: 5.251

2.  Fourth Universal Definition of Myocardial Infarction (2018).

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Bernard R Chaitman; Jeroen J Bax; David A Morrow; Harvey D White
Journal:  Circulation       Date:  2018-11-13       Impact factor: 29.690

3.  Prognostic impact of coronary microvascular dysfunction in patients with myocardial infarction with non-obstructive coronary arteries.

Authors:  Fuad A Abdu; Lu Liu; Abdul-Quddus Mohammed; Guoqing Yin; Bin Xu; Wen Zhang; Siling Xu; Xian Lv; Rui Fan; Cailin Feng; Tingting Shi; Yunlong Huo; Yawei Xu; Wenliang Che
Journal:  Eur J Intern Med       Date:  2021-06-03       Impact factor: 4.487

4.  Usefulness of the index of microcirculatory resistance for invasively assessing myocardial viability immediately after primary angioplasty for anterior myocardial infarction.

Authors:  Hong-Seok Lim; Myeong-Ho Yoon; Seung-Jea Tahk; Hyoung-Mo Yang; Byoung-Joo Choi; So-Yeon Choi; Seung-Soo Sheen; Gyo-Seung Hwang; Soo-Jin Kang; Joon-Han Shin
Journal:  Eur Heart J       Date:  2009-08-14       Impact factor: 29.983

5.  The Index of Microcirculatory Resistance Postpercutaneous Coronary Intervention Predicts Left Ventricular Recovery in Patients With Thrombolyzed ST-Segment Elevation Myocardial Infarction.

Authors:  Sonny Palmer; Jamie Layland; David Carrick; Paul D Williams; Christopher Judkins; Fei Fei Gong; Andrew T Burns; Robert J Whitbourn; Andrew I MacIsaac; Andrew M Wilson
Journal:  J Interv Cardiol       Date:  2016-01-29       Impact factor: 2.279

6.  Angio-Based Index of Microcirculatory Resistance for the Assessment of the Coronary Resistance: A Proof of Concept Study.

Authors:  Matteo Tebaldi; Simone Biscaglia; Domenico Di Girolamo; Andrea Erriquez; Carlo Penzo; Carlo Tumscitz; Gianluca Campo
Journal:  J Interv Cardiol       Date:  2020-10-25       Impact factor: 2.279

7.  Coronary Angiography-Derived Index of Microvascular Resistance.

Authors:  Hu Ai; Yundi Feng; Yanjun Gong; Bo Zheng; Qinhua Jin; Hui-Ping Zhang; Fucheng Sun; Jianping Li; Yundai Chen; Yunlong Huo; Yong Huo
Journal:  Front Physiol       Date:  2020-12-16       Impact factor: 4.566

8.  Early change in invasive measures of microvascular function can predict myocardial recovery following PCI for ST-elevation myocardial infarction.

Authors:  Florim Cuculi; Erica Dall'Armellina; Cedric Manlhiot; Alberto R De Caterina; Sharon Colyer; Vanessa Ferreira; Alireza Morovat; Bernard D Prendergast; J Colin Forfar; Nicholas J Alp; Robin P Choudhury; Stefan Neubauer; Keith M Channon; Adrian P Banning; Rajesh K Kharbanda
Journal:  Eur Heart J       Date:  2013-10-17       Impact factor: 29.983

9.  Functional Coronary Angiography-Derived Index of Microcirculatory Resistance in Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Ki Hong Choi; Neng Dai; YinLiang Li; Juwon Kim; Doosup Shin; Seung Hun Lee; Hyun Sung Joh; Hyun Kuk Kim; Ki-Hyun Jeon; Sang Jin Ha; Sung-Mok Kim; Mi Ja Jang; Taek Kyu Park; Jeong Hoon Yang; Young Bin Song; Joo-Yong Hahn; Joon-Hyung Doh; Eun-Seok Shin; Seung-Hyuk Choi; Hyeon-Cheol Gwon; Joo Myung Lee
Journal:  JACC Cardiovasc Interv       Date:  2021-08-09       Impact factor: 11.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.